A Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal Cancer
If these data pan out, this first-in-class antibody might be likened to Herceptin, or Rituxan. It may be the real deal, a precise treatment that works on malignant cells that have tested positive for the relevant molecule.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Elaine Schattner Source Type: news
More News: Cancer | Cancer & Oncology | Esophagus Cancer | Gastric (Stomach) Cancer | Herceptin | Pharmaceuticals | Rituxan